RETRACTED ARTICLE: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC

Castration-resistant prostate cancer (CRPC) is a highly malignant type of advanced cancer resistant to androgen deprivation therapy. One of the important mechanisms for the development of CRPC is the persistent imbalanced regulation of AR and AR splice variants (AR/AR-Vs). In this study, we reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Boya, Zhang, Mingpeng, Yang, Yanjie, Li, Qi, Yu, Jianpeng, Zhu, Shimiao, Niu, Yuanjie, Shang, Zhiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755543/
https://www.ncbi.nlm.nih.gov/pubmed/34759344
http://dx.doi.org/10.1038/s41388-021-02103-x